Pollard Julianne M, Gatti Richard A
Department of Radiation Physics, University of Texas M D Anderson Cancer Center, Houston, TX, USA.
Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1323-31. doi: 10.1016/j.ijrobp.2009.02.057.
Adverse reactions to radiotherapy represent a confounding phenomenon in radiation oncology. These reactions are rare, and many have been associated with individuals with DNA repair disorders such as ataxia-telangiectasia and Nijmegen Breakage syndrome. A paucity of published data is available detailing such circumstances. This overview describes four exemplary situations, a comprehensive list of 32 additional cases, and some insights gleaned from this overall experience. Fanconi anemia was associated with more than one-half of the reports. The lowest dose given to a patient that resulted in a reaction was 3 Gy, given to an ataxia-telangiectasia patient. Most patients died within months of exposure. It is clear that the patients discussed in this report had complicated illnesses, in addition to cancer, and the radiotherapy administered was most likely their best option. However, the underlying DNA repair defects make conventional radiation doses dangerous. Our findings support previous wisdom that radiotherapy should either be avoided or the doses should be selected with great care in the case of these radiosensitive genotypes, which must be recognized by their characteristic phenotypes, until more rapid, reliable, and functional assays of DNA repair become available.
放疗的不良反应是放射肿瘤学中一个令人困惑的现象。这些反应很少见,并且许多与患有DNA修复障碍的个体有关,如共济失调毛细血管扩张症和尼曼-匹克氏病。目前公开的数据很少详细描述此类情况。本综述描述了四种典型情况、另外32例病例的完整列表,以及从这一整体经验中获得的一些见解。范可尼贫血与超过一半的报告病例有关。导致不良反应的患者所接受的最低剂量为3Gy,是一名共济失调毛细血管扩张症患者。大多数患者在接触后数月内死亡。很明显,本报告中讨论的患者除了患有癌症外,还患有复杂疾病,并且所进行的放疗很可能是他们的最佳选择。然而,潜在的DNA修复缺陷使得常规放疗剂量变得危险。我们的研究结果支持了之前的观点,即在这些放射敏感基因型的情况下,要么应避免放疗,要么应极其谨慎地选择放疗剂量,在有更快速、可靠和功能性的DNA修复检测方法之前,必须通过其特征性表型来识别这些基因型。